Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Li H, Lyu W. Intestinal NK/T cell lymphoma: A case report. World J Gastroenterol 2020; 26(27): 3989-3997 [PMID: 32774072 DOI: 10.3748/wjg.v26.i27.3989]
World J Gastroenterol. Jul 21, 2020; 26(27): 3989-3997 Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3989
Intestinal NK/T cell lymphoma: A case report
Hui Li, Wen Lyu
Hui Li, Wen Lyu, Department of Gastroenterology, Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang Province, China
Author contributions: Li H and Lyu W designed this case report; Lyu W performed the endoscopy examination; Li H followed the patient, recorded her medical information, and wrote the paper.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report.
Conflict-of-interest statement: The authors declare that they have no competing interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Wen Lyu, MD, Chief Doctor, Director, Department of Gastroenterology, Hangzhou First People's Hospital, Zhejiang University School of Medicine, No. 4, Xueshi Road, Shangcheng District, Hangzhou 310000, Zhejiang Province, China. lihui-cy@163.com
Received: March 31, 2020 Peer-review started: March 31, 2020 First decision: April 29, 2020 Revised: June 9, 2020 Accepted: June 23, 2020 Article in press: June 23, 2020 Published online: July 21, 2020 Processing time: 112 Days and 7.8 Hours
Core Tip
Core tip: The incidence of intestinal NK/T cell lymphoma (NKTCL) is extremely low, and the clinical symptoms are atypical. The misdiagnosis rate is high, and the patient's prognosis is poor. It is commonly caused by Epstein-Barr virus infection. At present, the etiology of this disease is unclear. The patient in this case was eventually diagnosed with intestinal NKTCL. The patient’s condition did not improve after treatment with hormones and infliximab, and she eventually died. This case reminds us that more potential molecular markers need to be explored. The molecular regulatory network needs to be supplemented to help with the differential diagnosis. Clinicians and pathologists need to improve their awareness of this disease and reduce the rate of misdiagnosis.